Patents by Inventor Sun Hyung KWON

Sun Hyung KWON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation
    Patent number: 12178940
    Abstract: The formation of scars at a wound site is reduced by contacting the wound site with an effective dose of an inhibitor of focal adhesion kinase (FAK) formulated in a pullulan hydrogel The release profile of the FAK inhibitor can be adjusted according to the nature of the wound, e.g., excisional wounds, burn wounds, etc.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: December 31, 2024
    Inventors: Geoffrey C. Gurtner, Sun Hyung Kwon, Mohammed Inayathullah Nazir Ahmed, Jayakumar Rajadas
  • METHODS FOR TISSUE REGENERATION AND KITS THEREFOR
    Publication number: 20230121926
    Abstract: Methods are described herein for facilitating tissue regeneration in humans and other large organisms, and kits therefor. Application of an inhibitor of focal adhesion kinase (FAK) to injured tissue may reduce fibrosis and/or scarring during the wound healing process. Patient care for a large number of fibrotic diseases which affect organ function may be ameliorated by such treatment. Kits for application of the FAK inhibitor may include a hydrogel formulation encapsulating the FAK inhibitor.
    Type: Application
    Filed: January 25, 2021
    Publication date: April 20, 2023
    Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Geoffrey C. Gurtner, Kellen Chen, Sun Hyung Kwon, Dominic Henn
  • CONTROLLED HYDROGEL DELIVERY OF FOCAL ADHESION KINASE INHIBITOR FOR DECREASED SCAR FORMATION
    Publication number: 20210361833
    Abstract: The formation of scars at a wound site is reduced by contacting the wound site with an effective dose of an inhibitor of focal adhesion kinase (FAK) formulated in a pullulan hydrogel The release profile of the FAK inhibitor can be adjusted according to the nature of the wound, e.g., excisional wounds, burn wounds, etc.
    Type: Application
    Filed: May 16, 2019
    Publication date: November 25, 2021
    Inventors: Geoffrey C. GURTNER, Sun Hyung KWON, Mohammed Inayathullah NAZIR AHMED, Jayakumar RAJADAS